Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Pain Therapeutics Reviews Mid-Year Progress, Reports Second Quarter 2009 Financial Results
King and Pain Therapeutics Announce REMOXY(r) NDA Update
REMOXY(R) NDA Update
Pain Therapeutics Invited to Present At Two Investor Conferences
King Pharmaceuticals Reports First-Quarter 2009 Financial Results
Pain Therapeutics Initiates Clinical Study in Cancer Patients
Pain Therapeutics Announces First Quarter 2009 Financial Results
Pain Therapeutics to Present At the Barclays Capital Healthcare Conference
Pain Therapeutics Announces Year-End 2008 Financial Results, Outlines 2009 Business Priorities
Pain Therapeutics Receives Complete Response Letter From FDA for REMOXY(R)
Pain Therapeutics to Present At the Piper Jaffray Health Care Conference
Zacks Analyst Blog Highlights: Pain Therapeutics Inc., Animal Health International, Inc., Companhia Paranaense De Energia, Internap Network Services Corp. And Buckeye Partners, L.P.
Zacks Analyst Blog Highlights: Pain Therapeutics Inc., Animal HealthServices Corp. And Buckeye Partners, L.P.
Zacks Bull and Bear of the Day Highlights: SINA Corp., Pain Therapeutics, VeriSign, Commerce Bancshares and Buckeye Partners
Zacks Bull and Bear of the Day Highlights: SINA Corp., PainTherapeutics, VeriSign, Commerce Bancshares and Buckeye Partners
Pain Therapeutics to Present At Two Upcoming Investor Conferences - Nov 10 2008 9:30AM
Pain Therapeutics Announces Third Quarter 2008 Financial Results
Pain Therapeutics to Present At the UBS Life Sciences Conference
$20,000,000.00 Received by Pain Therapeutics
DURECT Announces the IND Submission for a Third Abuse-Resistant Opioid Pain Medication Based on Its ORADUR(TM) Technology
Pain Therapeutics and King Pharmaceuticals Develop a New Abuse-Resistant Prescription Pain Medication
Pain Therapeutics and King Pharmaceuticals Announce Final Data of REMOXY Phase III Study at World Pain Congress in Scotland
REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted
FDA Accepts REMOXY New Drug Application and Grants Priority Review
FDA Accepts REMOXY New Drug Application and Grants Priority Review
Pain Therapeutics Announces Second Quarter 2008 Financial Results
Pain Therapeutics Encouraged by Results of Melanoma Clinical Study
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy
Pain Therapeutics to Present At Two Upcoming Investor Conferences - Jun 3 2008 9:18AM
Pain Therapeutics Announces First Quarter 2008 Financial Results
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
